{
  "schema_version": "0.1.0",
  "case_id": "HR-ML019",
  "record_classification": {
    "synthetic": true,
    "banner": "SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD",
    "real_historical_name": true,
    "public_release_status": "draft"
  },
  "identity": {
    "person_id": "ML019",
    "display_name": "Ann Richards",
    "aliases": [
      "Dorothy Ann Willis",
      "Ann Willis Richards"
    ],
    "sex": "female",
    "era": "Mid-Late 20th Century",
    "nationality": "American",
    "historical_dates": {
      "birth": {
        "preferred": {
          "iso": "1933-09-01",
          "display": "September 1, 1933",
          "precision": "day",
          "calendar": "gregorian"
        },
        "alternatives": [
          {
            "date": {
              "iso": "1933",
              "display": "1933",
              "precision": "year",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0010"
            ],
            "resolution_status": "preferred",
            "note": "Roster year agrees with the cited sources."
          }
        ]
      },
      "death": {
        "preferred": {
          "iso": "2006-09-13",
          "display": "September 13, 2006",
          "precision": "day",
          "calendar": "gregorian"
        },
        "alternatives": [
          {
            "date": {
              "iso": "2006",
              "display": "2006",
              "precision": "year",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0010"
            ],
            "resolution_status": "preferred",
            "note": "Roster year agrees with the cited sources."
          }
        ]
      }
    },
    "synthetic_identity": {
      "mrn": "HR-ML019-SYN",
      "ssn": "000-19-3381",
      "date_of_birth": "1962-09-01",
      "name_policy": "real_historical_name",
      "fictional_facility": "St. Posthumous Health Center",
      "fictional_primary_clinician": "Rosalind Teague, MD",
      "fictional_consultant": {
        "name": "Marcus Delgado, MD",
        "specialty": "Endocrinology"
      }
    }
  },
  "historical_timeline": [
    {
      "event_id": "EVT-0001",
      "date": {
        "iso": "1933-09-01",
        "display": "September 1, 1933",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Born Dorothy Ann Willis in Lakeview, near Waco, Texas.",
      "claim_ids": [
        "CLM-0001"
      ]
    },
    {
      "event_id": "EVT-0002",
      "date": {
        "iso": "1980",
        "display": "1980",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Enters treatment for alcohol use and emerges sober.",
      "claim_ids": [
        "CLM-0003"
      ]
    },
    {
      "event_id": "EVT-0003",
      "date": {
        "iso": "1982",
        "display": "1982",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Elected Texas state treasurer; keynote address at the 1988 Democratic National Convention; elected governor in 1990.",
      "claim_ids": [
        "CLM-0002"
      ]
    },
    {
      "event_id": "EVT-0004",
      "date": {
        "iso": "1996",
        "display": "1996 (1994 in one source)",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Falls and breaks her hand; a bone density test shows osteopenia, described as early osteoporosis.",
      "claim_ids": [
        "CLM-0005",
        "CLM-0006",
        "CLM-0007"
      ]
    },
    {
      "event_id": "EVT-0005",
      "date": {
        "iso": "2003",
        "display": "2003",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Publishes I'm Not Slowing Down: Winning My Battle with Osteoporosis; reports that her bone density has stabilized.",
      "claim_ids": [
        "CLM-0008",
        "CLM-0009",
        "CLM-0010"
      ]
    },
    {
      "event_id": "EVT-0006",
      "date": {
        "iso": "2006-09-13",
        "display": "September 13, 2006",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Dies at home in Austin, six months after esophageal cancer was found.",
      "claim_ids": [
        "CLM-0011"
      ]
    }
  ],
  "claims": [
    {
      "claim_id": "CLM-0001",
      "statement": "Ann Richards was born Dorothy Ann Willis on September 1, 1933, in Lakeview, near Waco, Texas.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "source_links": [
        {
          "source_id": "SRC-0008",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0007",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0002",
      "statement": "She was elected Texas state treasurer in 1982, gave the keynote address at the 1988 Democratic National Convention, was elected governor of Texas in 1990, and served one term after losing her bid for re-election in 1994.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Used for the synthetic modern occupation (public speaker and adviser).",
      "source_links": [
        {
          "source_id": "SRC-0006",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0009",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0003",
      "statement": "She spoke openly about her past heavy drinking (\"I smoked like a chimney and drank like a fish\"), entered treatment, and emerged sober; one biography dates the treatment to 1980 and describes it as successful.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Her own public account of alcohol use disorder and long recovery, and of past heavy smoking. Used for the synthetic problem of alcohol use disorder in sustained remission and for the former-smoker history; the quit date for tobacco is not documented.",
      "source_links": [
        {
          "source_id": "SRC-0006",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0007",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0004",
      "statement": "She said publicly that her mother had osteoporosis, broke \"her arm, her hip,\" and developed a hump, and that osteoporosis was not the cause of her mother's death but led to it.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Her own public account of her mother's illness. Used for the family history and the parental hip fracture entered in FRAX.",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0005",
      "statement": "Because of her mother's fractures, she asked her doctor at an annual checkup to test her bone density.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Her own public account.",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0006",
      "statement": "She had a bone density test after falling and breaking her hand. CBS News (2003) and a publisher's summary date this to 1996, and CBS says she fell twice and broke her hand and her ankle; a Publishers Weekly review dates the hand fracture to 1994.",
      "evidence_grade": "D",
      "certainty": "probable",
      "clinical_interpretation": "The hand fracture is consistent across sources; its year (1996 in two sources, 1994 in one) and the ankle fracture (one source) are not. The case uses a fall with a hand fracture the year before the index visit and records the ankle fracture as reported in one source.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0007",
      "statement": "The bone density test showed osteopenia, which CBS News and the publisher's summary call an early stage of osteoporosis; in other interviews she said she had osteoporosis or early osteoporosis.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "The published label is low bone mass (osteopenia), described as early osteoporosis. No source gives her T-scores; the synthetic T-scores stay in the low bone mass range.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0008",
      "statement": "CBS News reported in 2003 that she had shrunk three-quarters of an inch; in a 2002 television interview she said \"my neck bones were collapsing and I literally was shrinking.\"",
      "evidence_grade": "D",
      "certainty": "probable",
      "clinical_interpretation": "Lay description of height loss; no source reports a vertebral fracture. Used only for the measured height loss of about 2 cm in the synthetic examination.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0009",
      "statement": "She took a prescription medicine, began weight-bearing exercise and weight training, and changed her diet; CBS News reported in 2003 that her bone density had stabilized, and that she was a spokesperson for the maker of the medicine she took.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Her public account of treatment. The product is not named in this record, and the synthetic treatment is chosen by guideline and her synthetic data, not by her real treatment.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0010",
      "statement": "In 2003 she published I'm Not Slowing Down: Winning My Battle with Osteoporosis, written with Richard U. Levine, MD, to encourage women and men to ask their doctors for a bone density test.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "source_links": [
        {
          "source_id": "SRC-0004",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0010",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0011",
      "statement": "She was found to have esophageal cancer in March 2006, received chemotherapy, and died at her home in Austin on September 13, 2006, at 73.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "History only; after the true-frame episode and not used in it.",
      "source_links": [
        {
          "source_id": "SRC-0009",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0008",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0007",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    }
  ],
  "sources": [
    {
      "source_id": "SRC-0001",
      "title": "Morales T. Ann Richards' Latest Battle",
      "publisher": "CBS News",
      "url": "https://www.cbsnews.com/news/ann-richards-latest-battle",
      "source_type": "other",
      "published": "2003-08-11",
      "accessed": "2026-11-03",
      "rights_note": "News report quoting her; facts used with citation."
    },
    {
      "source_id": "SRC-0002",
      "title": "Ann Richards on osteoporosis (CBS News report)",
      "publisher": "CBS News",
      "url": "https://www.cbsnews.com/news/ann-richards-osteoporosis-campaign/",
      "source_type": "other",
      "published": "2000-11-30",
      "accessed": "2026-11-03",
      "rights_note": "News report quoting her; facts used with citation."
    },
    {
      "source_id": "SRC-0003",
      "title": "Larry King Live transcript, May 14, 2002",
      "publisher": "CNN",
      "url": "https://transcripts.cnn.com/show/lkl/date/2002-05-14/segment/00",
      "source_type": "other",
      "published": "2002-05-14",
      "accessed": "2026-11-03",
      "rights_note": "Interview transcript; her own words quoted briefly with citation."
    },
    {
      "source_id": "SRC-0004",
      "title": "Review: I'm Not Slowing Down: Winning My Battle with Osteoporosis",
      "publisher": "Publishers Weekly",
      "url": "https://www.publishersweekly.com/9780525946915",
      "source_type": "other",
      "published": "2003",
      "accessed": "2026-11-03",
      "rights_note": "Book review; facts used with citation."
    },
    {
      "source_id": "SRC-0005",
      "title": "Winning My Battle with Osteoporosis (book description)",
      "publisher": "Texas Cooking",
      "url": "https://texascooking.com/books/osteoporosisannrichards.htm",
      "source_type": "other",
      "published": "2003",
      "accessed": "2026-11-03",
      "rights_note": "Publisher's book summary reproduced on a book page; facts used with citation."
    },
    {
      "source_id": "SRC-0006",
      "title": "Ann W. Richards (governor's biography)",
      "publisher": "Texas State Library and Archives Commission",
      "url": "https://www.tsl.texas.gov/governors/modern/richards-p01.html",
      "source_type": "government",
      "published": "undated",
      "accessed": "2026-11-03",
      "rights_note": "State archive biography; facts used with citation."
    },
    {
      "source_id": "SRC-0007",
      "title": "Ann Richards (Research Starters biography)",
      "publisher": "EBSCO",
      "url": "https://www.ebsco.com/research-starters/biography/ann-richards/",
      "source_type": "biography",
      "published": "undated",
      "accessed": "2026-11-03",
      "rights_note": "Reference biography; facts used with citation."
    },
    {
      "source_id": "SRC-0008",
      "title": "Ann Willis Richards (plot holder record)",
      "publisher": "Texas State Cemetery",
      "url": "https://cemetery.texas.gov/locate-a-plot/plotholder/ann-willis-richards",
      "source_type": "government",
      "published": "undated",
      "accessed": "2026-11-03",
      "rights_note": "State cemetery record with an Associated Press obituary; facts used with citation."
    },
    {
      "source_id": "SRC-0009",
      "title": "Ann Richards dies at 73 (Associated Press)",
      "publisher": "The Spokesman-Review",
      "url": "https://www.spokesman.com/stories/2006/sep/14/ann-richards-dies-at-73",
      "source_type": "other",
      "published": "2006-09-14",
      "accessed": "2026-11-03",
      "rights_note": "Wire-service obituary; facts used with citation."
    },
    {
      "source_id": "SRC-0010",
      "title": "HISTMED Master Roster v3",
      "publisher": "The Human Record project",
      "url": "https://humanrecord.example.org/internal/HISTMED_Master_Roster_v3.xlsx",
      "source_type": "other",
      "published": "2026-11-03",
      "accessed": "2026-11-03",
      "rights_note": "Internal source locator; inherited claims remain provisional until corroborated."
    }
  ],
  "synthetic_episode": {
    "calendar_frame": "modern_shifted",
    "index_date": "2026-02-10",
    "index_age": 63,
    "date_shift_policy": "HR-DATE-SHIFT-1",
    "teaching_objective": "Evaluate bone health in a 63-year-old postmenopausal woman after a fall with a hand fracture: read the DXA T-scores precisely (low bone mass, not osteoporosis by T-score), calculate FRAX with her risk factors, and base the treatment decision on the guideline thresholds; complete a secondary-causes work-up and correct vitamin D before an antiresorptive; choose therapy strictly by guideline and her risk; add calcium, vitamin D, weight-bearing and balance exercise, and falls prevention; set the DXA follow-up interval and the drug-holiday reassessment; and give recovery-oriented care for an alcohol use disorder in long remission, with a structured safety assessment, on the CMID osteoporosis schedule.",
    "visit_schedule": [
      {
        "encounter_id": "ENC-001",
        "date": "2026-02-10",
        "purpose": "New patient visit for bone health after a fall with a hand fracture"
      },
      {
        "encounter_id": "ENC-002",
        "date": "2026-03-10",
        "purpose": "Four-week bone health review with endocrinology consultation"
      },
      {
        "encounter_id": "ENC-003",
        "date": "2026-05-12",
        "purpose": "Three-month bone health review and first zoledronic acid infusion"
      },
      {
        "encounter_id": "ENC-004",
        "date": "2026-08-11",
        "purpose": "Six-month bone health review, three months after the first infusion"
      },
      {
        "encounter_id": "ENC-005",
        "date": "2026-10-06",
        "purpose": "Adult preventive visit"
      }
    ]
  },
  "clinical": {
    "problems": [
      {
        "id": "PRB-001",
        "display": "Low bone mass (osteopenia) of the lumbar spine and hip on DXA, lowest T-score -2.3 at the lumbar spine (femoral neck -2.0, total hip -1.7), with a 10-year FRAX risk above the treatment thresholds (major osteoporotic fracture 22 percent, hip 3.6 percent); not osteoporosis by T-score, but meets the AACE 2020 clinical criteria for osteoporosis (low bone mass with a FRAX risk above threshold)",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "M85.89",
            "display": "Other specified disorders of bone density and structure, multiple sites",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0006",
            "CLM-0007",
            "CLM-0004"
          ],
          "synthetic_reason": "Synthetic modern DXA and FRAX classification linked to her publicly described osteopenia (early osteoporosis) after a fall with a hand fracture.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "both_with_link"
      },
      {
        "id": "PRB-002",
        "display": "Alcohol use disorder in sustained remission for more than fifteen years, since treatment; no alcohol since",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "F10.21",
            "display": "Alcohol dependence, in remission",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003"
          ],
          "synthetic_reason": "Synthetic modern coding of her publicly described heavy drinking and long recovery; listed because remission protects bone and lowers fall risk, and it is reviewed at each visit.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "both_with_link"
      },
      {
        "id": "PRB-003",
        "display": "History of falls: a fall from standing height with a hand fracture last year (and, in one account, a second fall with an ankle fracture); no falls since",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "Z91.81",
            "display": "History of falling",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic modern entry linked to her publicly described falls and fractures.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "both_with_link"
      }
    ],
    "medications": [
      {
        "id": "MED-001",
        "display": "Cholecalciferol (vitamin D3) 50 mcg (2000 units) oral tablet, one tablet daily",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "801663",
            "display": "cholecalciferol 0.05 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "dose": {
          "value": 50,
          "unit": "ug"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet by mouth daily"
        },
        "start_date": "2026-02-10",
        "indication_problem_ids": [
          "PRB-001"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vitamin D repletion to a 25-hydroxyvitamin D of 30 ng/mL or more before an antiresorptive, then maintenance.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "MED-002",
        "display": "Zoledronic acid 5 mg in 100 mL intravenous infusion over 30 minutes, once every 12 months",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "705824",
            "display": "100 ML zoledronic acid 0.05 MG/ML Injection",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "dose": {
          "value": 5,
          "unit": "mg"
        },
        "route": "intravenous",
        "frequency": {
          "period": 52,
          "period_unit": "wk",
          "text": "Once every 12 months, given in the clinic infusion room after a calcium and creatinine check"
        },
        "start_date": "2026-05-12",
        "indication_problem_ids": [
          "PRB-001"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic first-line antiresorptive chosen by the AACE 2020, Endocrine Society, and BHOF guidelines for her risk (proven hip, vertebral, and nonvertebral fracture reduction), with once-yearly dosing that suits her travel; not her real treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "MED-003",
        "display": "Acetaminophen 500 mg oral tablet, two tablets every 6 hours as needed for aches or fever for up to three days after the infusion (no more than 3 g a day)",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "198440",
            "display": "acetaminophen 500 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "dose": {
          "value": 1000,
          "unit": "mg"
        },
        "route": "oral",
        "frequency": {
          "period": 6,
          "period_unit": "h",
          "text": "Two tablets every 6 hours as needed for up to three days after the infusion"
        },
        "start_date": "2026-05-12",
        "end_date": "2026-05-15",
        "indication_problem_ids": [
          "PRB-001"
        ],
        "as_needed": true,
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic treatment of the expected acute-phase reaction after a first zoledronic acid dose.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      }
    ],
    "allergies": [
      {
        "id": "ALG-001",
        "display": "No known allergy",
        "status": "active",
        "assertion": "no_known_allergy",
        "substance": {
          "system": "http://snomed.info/sct",
          "code": "716186003",
          "display": "No known allergy"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic allergy assertion for EHR completeness; not a historical assertion.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      }
    ],
    "observations": [
      {
        "id": "OBS-DXASPINE-V1",
        "display": "DXA Lumbar spine [T-score] Bone density",
        "label": "Lumbar spine (L1-L4) T-score",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-02-10",
        "value": -2.3,
        "unit": "{T-score}",
        "reference_range": {
          "low": -1.0,
          "text": "-1.0 or higher is normal; between -1.0 and -2.5 is low bone mass (osteopenia); -2.5 or lower is osteoporosis"
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "38267-1",
            "display": "DXA Lumbar spine [T-score] Bone density",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0006",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic baseline DXA on this clinic's scanner. Her published diagnosis was osteopenia; no source gives her T-scores, and the synthetic values stay in the low bone mass range.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-DXAFN-V1",
        "display": "DXA Femur [T-score] Bone density",
        "label": "Femoral neck T-score",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-02-10",
        "value": -2.0,
        "unit": "{T-score}",
        "reference_range": {
          "low": -1.0,
          "text": "-1.0 or higher is normal; between -1.0 and -2.5 is low bone mass (osteopenia); -2.5 or lower is osteoporosis"
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "38263-0",
            "display": "DXA Femur [T-score] Bone density",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0006",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic baseline DXA on this clinic's scanner. Her published diagnosis was osteopenia; no source gives her T-scores, and the synthetic values stay in the low bone mass range.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-DXAHIP-V1",
        "display": "DXA Hip [T-score] Bone density",
        "label": "Total hip T-score",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-02-10",
        "value": -1.7,
        "unit": "{T-score}",
        "reference_range": {
          "low": -1.0,
          "text": "-1.0 or higher is normal; between -1.0 and -2.5 is low bone mass (osteopenia); -2.5 or lower is osteoporosis"
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "38264-8",
            "display": "DXA Hip [T-score] Bone density",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0006",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic baseline DXA on this clinic's scanner. Her published diagnosis was osteopenia; no source gives her T-scores, and the synthetic values stay in the low bone mass range.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-FRAXMOF-V1",
        "display": "Major osteoporotic fracture 10-year probability [Likelihood] Fracture Risk Assessment",
        "label": "FRAX 10-year major osteoporotic fracture risk",
        "status": "final",
        "effective_date": "2026-02-10",
        "value": 22,
        "unit": "%",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "90265-0",
            "display": "Major osteoporotic fracture 10-year probability [Likelihood] Fracture Risk Assessment",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic US FRAX with femoral neck BMD: age 63, female, BMI 24.5, previous fracture yes (hand fracture in a fall from standing height), parent hip fracture yes (her public account of her mother), current smoking no, glucocorticoids no, rheumatoid arthritis no, secondary osteoporosis no, alcohol 3 or more units a day no.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-FRAXHIP-V1",
        "display": "Hip fracture 10-year probability [Likelihood] Fracture Risk Assessment",
        "label": "FRAX 10-year hip fracture risk",
        "status": "final",
        "effective_date": "2026-02-10",
        "value": 3.6,
        "unit": "%",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "90266-8",
            "display": "Hip fracture 10-year probability [Likelihood] Fracture Risk Assessment",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic US FRAX with femoral neck BMD: age 63, female, BMI 24.5, previous fracture yes (hand fracture in a fall from standing height), parent hip fracture yes (her public account of her mother), current smoking no, glucocorticoids no, rheumatoid arthritis no, secondary osteoporosis no, alcohol 3 or more units a day no.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-CA-V1",
        "display": "Calcium [Mass/volume] in Serum or Plasma",
        "label": "Calcium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-10",
        "value": 9.4,
        "unit": "mg/dL",
        "reference_range": {
          "low": 8.6,
          "high": 10.3
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "17861-6",
            "display": "Calcium [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic normal secondary-causes result for low bone mass.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALB-V1",
        "display": "Albumin [Mass/volume] in Serum or Plasma",
        "label": "Albumin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-10",
        "value": 4.2,
        "unit": "g/dL",
        "reference_range": {
          "low": 3.5,
          "high": 5.0
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1751-7",
            "display": "Albumin [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic normal secondary-causes result for low bone mass.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-CREAT-V1",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-10",
        "value": 0.8,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.5,
          "high": 1.0
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic normal secondary-causes result for low bone mass.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V1",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-10",
        "value": 81,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic normal secondary-causes result for low bone mass.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHOS-V1",
        "display": "Phosphate [Mass/volume] in Serum or Plasma",
        "label": "Phosphate",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-10",
        "value": 3.5,
        "unit": "mg/dL",
        "reference_range": {
          "low": 2.5,
          "high": 4.5
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2777-1",
            "display": "Phosphate [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic normal secondary-causes result for low bone mass.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-MG-V1",
        "display": "Magnesium [Mass/volume] in Serum or Plasma",
        "label": "Magnesium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-10",
        "value": 2.0,
        "unit": "mg/dL",
        "reference_range": {
          "low": 1.7,
          "high": 2.4
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "19123-9",
            "display": "Magnesium [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic normal secondary-causes result for low bone mass.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALP-V1",
        "display": "Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "Alkaline phosphatase",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-10",
        "value": 84,
        "unit": "U/L",
        "reference_range": {
          "low": 40,
          "high": 120
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6768-6",
            "display": "Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic normal secondary-causes result for low bone mass.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-PTH-V1",
        "display": "Parathyrin.intact [Mass/volume] in Serum or Plasma",
        "label": "PTH",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-10",
        "value": 54,
        "unit": "pg/mL",
        "reference_range": {
          "low": 15,
          "high": 65
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2731-8",
            "display": "Parathyrin.intact [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic normal secondary-causes result for low bone mass.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-TSH-V1",
        "display": "Thyrotropin [Units/volume] in Serum or Plasma",
        "label": "TSH",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-10",
        "value": 1.9,
        "unit": "m[IU]/L",
        "reference_range": {
          "low": 0.4,
          "high": 4.0
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "3016-3",
            "display": "Thyrotropin [Units/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic normal secondary-causes result for low bone mass.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V1",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-10",
        "value": 13.3,
        "unit": "g/dL",
        "reference_range": {
          "low": 12.0,
          "high": 15.5
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic normal secondary-causes result for low bone mass.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V1",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-10",
        "value": 21,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 35
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic normal secondary-causes result for low bone mass.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-VITD-V1",
        "display": "25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma",
        "label": "25-hydroxyvitamin D",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-10",
        "value": 24,
        "unit": "ng/mL",
        "reference_range": {
          "low": 30,
          "high": 100,
          "text": "Target 30 ng/mL or higher before and during osteoporosis treatment"
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "62292-8",
            "display": "25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vitamin D insufficiency (below the 30 ng/mL target), with a normal PTH; replete before an antiresorptive.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-CTX-V1",
        "display": "Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma",
        "label": "Serum CTX (fasting morning sample)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-10",
        "value": 560,
        "unit": "pg/mL",
        "reference_range": {
          "low": 104,
          "high": 1008,
          "text": "Postmenopausal reference interval 104 to 1008 pg/mL; a fall of more than about 30 percent on antiresorptive therapy indicates response"
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "41171-0",
            "display": "Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline fasting morning bone-turnover marker before treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V1",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-02-10",
        "value": 2,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic minimal depressive symptoms.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-AUDITC-V1",
        "display": "Total score [AUDIT-C]",
        "label": "AUDIT-C",
        "status": "final",
        "effective_date": "2026-02-10",
        "value": 0,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "75626-2",
            "display": "Total score [AUDIT-C]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003"
          ],
          "synthetic_reason": "Synthetic alcohol screen: no alcohol, consistent with her long public recovery.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-VITD-V3",
        "display": "25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma",
        "label": "25-hydroxyvitamin D",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-12",
        "value": 38,
        "unit": "ng/mL",
        "reference_range": {
          "low": 30,
          "high": 100,
          "text": "Target 30 ng/mL or higher before and during osteoporosis treatment"
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "62292-8",
            "display": "25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic 25-hydroxyvitamin D after three months of 2000 units a day.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-CA-V3",
        "display": "Calcium [Mass/volume] in Serum or Plasma",
        "label": "Calcium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-12",
        "value": 9.5,
        "unit": "mg/dL",
        "reference_range": {
          "low": 8.6,
          "high": 10.3
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "17861-6",
            "display": "Calcium [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic pre-infusion calcium.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-CREAT-V3",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-12",
        "value": 0.8,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.5,
          "high": 1.0
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic pre-infusion creatinine.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V3",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-12",
        "value": 81,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic pre-infusion eGFR, well above the 35 mL/min threshold for zoledronic acid.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-UCA24-V3",
        "display": "Calcium [Mass/time] in 24 hour Urine",
        "label": "24-hour urine calcium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-12",
        "value": 172,
        "unit": "mg/(24.h)",
        "reference_range": {
          "low": 100,
          "high": 300
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6874-2",
            "display": "Calcium [Mass/time] in 24 hour Urine",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic normal 24-hour urine calcium, collected late (protocol deviation recorded at visit 3).",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-CTX-V4",
        "display": "Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma",
        "label": "Serum CTX (fasting morning sample)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-11",
        "value": 190,
        "unit": "pg/mL",
        "reference_range": {
          "low": 104,
          "high": 1008,
          "text": "Postmenopausal reference interval 104 to 1008 pg/mL; a fall of more than about 30 percent on antiresorptive therapy indicates response"
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "41171-0",
            "display": "Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic fasting CTX three months after the first zoledronic acid dose: a 66 percent fall, showing response and adherence.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-CA-V4",
        "display": "Calcium [Mass/volume] in Serum or Plasma",
        "label": "Calcium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-11",
        "value": 9.3,
        "unit": "mg/dL",
        "reference_range": {
          "low": 8.6,
          "high": 10.3
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "17861-6",
            "display": "Calcium [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic calcium after the first dose.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-CHOL-V5",
        "display": "Cholesterol [Mass/volume] in Serum or Plasma",
        "label": "Total cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-06",
        "value": 204,
        "unit": "mg/dL",
        "reference_range": {
          "high": 199
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2093-3",
            "display": "Cholesterol [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid screening at the preventive visit.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-HDL-V5",
        "display": "Cholesterol in HDL [Mass/volume] in Serum or Plasma",
        "label": "HDL cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-06",
        "value": 62,
        "unit": "mg/dL",
        "reference_range": {
          "low": 50
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2085-9",
            "display": "Cholesterol in HDL [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid screening at the preventive visit.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-LDL-V5",
        "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation",
        "label": "LDL cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-06",
        "value": 118,
        "unit": "mg/dL",
        "reference_range": {
          "high": 129
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "13457-7",
            "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid screening at the preventive visit.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-TG-V5",
        "display": "Triglyceride [Mass/volume] in Serum or Plasma",
        "label": "Triglycerides",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-06",
        "value": 120,
        "unit": "mg/dL",
        "reference_range": {
          "high": 149
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2571-8",
            "display": "Triglyceride [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid screening at the preventive visit.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ2-V5",
        "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
        "label": "PHQ-2",
        "status": "final",
        "effective_date": "2026-10-06",
        "value": 0,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "55758-7",
            "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic negative depression screen at the preventive visit.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-AUDITC-V5",
        "display": "Total score [AUDIT-C]",
        "label": "AUDIT-C",
        "status": "final",
        "effective_date": "2026-10-06",
        "value": 0,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "75626-2",
            "display": "Total score [AUDIT-C]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic alcohol screen at the preventive visit; no alcohol, consistent with her long public recovery.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      }
    ],
    "procedures": [
      {
        "id": "PROC-001",
        "display": "Dual-energy X-ray absorptiometry of the lumbar spine and hip: L1-L4 T-score -2.3, femoral neck -2.0, total hip -1.7 (low bone mass)",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "241686001",
            "display": "Dual energy X-ray absorptiometry",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "period": {
          "start": "2026-02-10",
          "end": "2026-02-10"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0006",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic new baseline DXA; no earlier report was available.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "PROC-002",
        "display": "Vertebral fracture assessment by lateral spine DXA, T4 to L4: no vertebral fracture; mild degenerative change",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "726548004",
            "display": "Dual energy X-ray absorptiometry of bone of lateral spine",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "period": {
          "start": "2026-02-10",
          "end": "2026-02-10"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic vertebral imaging prompted by the recent low-trauma fracture and the height loss she described; no source reports a vertebral fracture.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "PROC-003",
        "display": "Supervised balance and strength exercise program with a physical therapist, 16 sessions over eight weeks, then a home program",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "386293009",
            "display": "Balance exercises",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "period": {
          "start": "2026-03-16",
          "end": "2026-05-08"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic falls-prevention exercise program after falls with fracture.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "PROC-004",
        "display": "Zoledronic acid 5 mg intravenous infusion over 30 minutes, first yearly dose, after a normal calcium, creatinine, and vitamin D check",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "700105003",
            "display": "Zoledronic acid therapy",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "period": {
          "start": "2026-05-12",
          "end": "2026-05-12"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic first dose of guideline-chosen therapy.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "PROC-005",
        "display": "Advance care planning conversation, about 20 minutes",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "713603004",
            "display": "Advance care planning",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "period": {
          "start": "2026-10-06",
          "end": "2026-10-06"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic voluntary advance care planning at the preventive visit; no specific treatment preference is recorded.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      }
    ],
    "immunizations": [
      {
        "id": "IMM-001",
        "display": "Influenza vaccine, 2025-2026 season",
        "status": "completed",
        "date": "2025-10-14",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "140",
            "display": "Influenza, split virus, trivalent, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic adult immunization history in the modern frame; not a historical assertion.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "IMM-002",
        "display": "Recombinant zoster vaccine, two-dose series completed",
        "status": "completed",
        "date": "2023-05-16",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "187",
            "display": "zoster recombinant",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic immunization history in the modern frame; not a historical assertion.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "IMM-003",
        "display": "Tdap vaccine",
        "status": "completed",
        "date": "2019-06-11",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "115",
            "display": "Tdap",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic immunization history in the modern frame; not a historical assertion.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "IMM-004",
        "display": "Influenza vaccine, 2026-2027 season",
        "status": "completed",
        "date": "2026-10-06",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "140",
            "display": "Influenza, split virus, trivalent, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic yearly influenza vaccination.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "IMM-005",
        "display": "Pneumococcal conjugate vaccine PCV20, single dose",
        "status": "completed",
        "date": "2026-10-06",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "216",
            "display": "Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic single dose recommended for all adults 50 and older.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      }
    ],
    "family_history": [
      {
        "id": "FH-001",
        "relationship": {
          "system": "http://terminology.hl7.org/CodeSystem/v3-RoleCode",
          "code": "MTH",
          "display": "mother"
        },
        "condition": "Osteoporosis with fractures of the arm and hip and a curved upper back, by Richards's own public account; Richards said osteoporosis was not the cause of her mother's death but led to it",
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0004"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      }
    ],
    "past_medical_history": [
      {
        "id": "PMH-001",
        "display": "Heavy drinking, followed by treatment from which she emerged sober; no alcohol since",
        "historical_date": {
          "iso": "1980",
          "display": "1980",
          "precision": "year",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0003"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "PMH-002",
        "display": "Fall with a hand fracture (one account also describes a second fall with an ankle fracture); the year is 1996 in two sources and 1994 in one",
        "historical_date": {
          "iso": "1996",
          "display": "1996",
          "precision": "year",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "PMH-003",
        "display": "Bone density test after the fall, reported as osteopenia, an early stage of osteoporosis; no report or T-scores available",
        "historical_date": {
          "iso": "1996",
          "display": "1996",
          "precision": "year",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0005",
            "CLM-0007"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      }
    ],
    "encounters": [
      {
        "id": "ENC-001",
        "display": "New patient visit for bone health after a fall with a hand fracture",
        "status": "finished",
        "date": "2026-02-10",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "ENC-002",
        "display": "Four-week bone health review with endocrinology consultation",
        "status": "finished",
        "date": "2026-03-10",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-03"
        },
        "documentation": {
          "chief_complaint": "Four-week bone health review",
          "hpi": {
            "narrative": "Ms. Richards returns four weeks after her intake visit. She takes vitamin D3 2000 units every day. She has added yogurt, cheese, and calcium-fortified orange juice, and her three-day food record shows about 1200 mg of calcium a day. She keeps walking and lifting weights and has had no falls. She did not collect the 24-hour urine sample before this visit because she was traveling for three weeks. She saw the endocrinologist this morning. Her balance and strength program with the physical therapist starts next week, and she has a routine dental examination booked next month. She has had no alcohol and no cravings.",
            "elements": [
              {
                "label": "Calcium intake",
                "value": "About 1200 mg a day from food by three-day record"
              },
              {
                "label": "Vitamin D",
                "value": "D3 2000 units daily, no missed doses"
              },
              {
                "label": "Falls",
                "value": "None"
              },
              {
                "label": "Pending tests",
                "value": "24-hour urine calcium not yet collected"
              },
              {
                "label": "Recovery",
                "value": "No alcohol; no cravings"
              }
            ]
          },
          "ros": [
            {
              "system": "Musculoskeletal",
              "status": "negative",
              "finding": "No back pain, new bone pain, or fracture; the healed hand is not painful"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No dizziness or unsteadiness"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "No constipation since adding dairy foods"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood good; no cravings; no thoughts of self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well and animated; weight 66.2 kg"
            },
            {
              "system": "Spine",
              "finding": "No tenderness or kyphosis; occiput touches the wall"
            },
            {
              "system": "Gait and balance",
              "finding": "Gait steady; tandem stance 8 seconds, unchanged"
            },
            {
              "system": "Mouth",
              "finding": "Good dentition; no exposed bone or gum swelling"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-001",
              "display": "Low bone mass with high fracture risk by FRAX",
              "assessment": "Lumbar spine T-score -2.3, femoral neck -2.0, and total hip -1.7: low bone mass, not osteoporosis by T-score. FRAX 22 percent for a major osteoporotic fracture and 3.6 percent for hip fracture, both above the treatment thresholds of 20 and 3 percent. Secondary-causes tests are normal apart from vitamin D of 24 ng/mL, now being repleted; the 24-hour urine calcium is outstanding. The endocrinologist agrees that treatment is indicated and recommends zoledronic acid once vitamin D is 30 ng/mL or more and the dental examination is done",
              "plan": [
                "Continue vitamin D3 2000 units daily and about 1200 mg of calcium a day from food",
                "Collect the 24-hour urine calcium before the three-month visit; container and written instructions given again",
                "Recheck 25-hydroxyvitamin D, calcium, and creatinine at three months; first zoledronic acid infusion that day if they are in range",
                "Routine dental examination next month"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "History of falls",
              "assessment": "No falls since intake; balance below normal (tandem stance 8 seconds)",
              "plan": [
                "Balance and strength program with the physical therapist from next week, twice a week for eight weeks"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Alcohol use disorder in sustained remission",
              "assessment": "No alcohol or cravings. Safety reviewed: no thoughts of suicide or self-harm; the 988 Suicide & Crisis Lifeline is saved in her phone",
              "plan": [
                "Continue the recovery check at each visit"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "laboratory",
              "measure": "Secondary-causes work-up",
              "cadence": "At diagnosis: calcium, albumin, phosphate, magnesium, alkaline phosphatase, creatinine and eGFR, PTH, 25-hydroxyvitamin D, TSH, blood count, and 24-hour urine calcium",
              "status": "up_to_date",
              "detail": "At intake: calcium 9.4 mg/dL, albumin 4.2 g/dL, phosphate 3.5, magnesium 2.0, alkaline phosphatase 84 U/L, creatinine 0.8 mg/dL (eGFR 81), PTH 54 pg/mL, TSH 1.9, hemoglobin 13.3, all normal; 25-hydroxyvitamin D 24 ng/mL, low",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-BHOF-2022",
                "GL-AACE-2020",
                "GL-ENDO-2019"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "24-hour urine calcium",
              "cadence": "At diagnosis, before starting therapy",
              "status": "deferred",
              "detail": "Ordered at intake to be collected before today; not collected because she was traveling. Deviation from the baseline work-up. No harm so far, because no drug has been started. Corrective action: container and instructions given again, and the result is required before the first infusion",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-BHOF-2022",
                "GL-AACE-2020"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "25-hydroxyvitamin D",
              "cadence": "At baseline; after repletion until 30 ng/mL or more; then yearly",
              "status": "due",
              "detail": "24 ng/mL at intake; recheck at three months, before the first infusion",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-BHOF-2022",
                "GL-AACE-2020"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Serum calcium before each intravenous antiresorptive dose",
              "cadence": "Before each zoledronic acid dose",
              "status": "due",
              "detail": "Planned at three months, before the first infusion",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-BHOF-2022",
                "GL-AACE-2020"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Bone-turnover marker (fasting serum CTX)",
              "cadence": "Baseline, then 3 to 6 months after starting or changing therapy",
              "status": "up_to_date",
              "detail": "560 pg/mL at intake; repeat three months after the first dose",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-BHOF-2022",
                "GL-AACE-2020"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Central DXA of the spine and hip",
              "cadence": "Every 1 to 2 years on therapy until stable, on the same scanner",
              "status": "up_to_date",
              "detail": "Baseline at intake; repeat two years after starting therapy",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-BHOF-2022",
                "GL-AACE-2020",
                "GL-ENDO-2019"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Vertebral fracture assessment",
              "cadence": "At baseline with a recent low-trauma fracture, height loss of 4 cm or more, or a T-score of -2.5 or lower",
              "status": "up_to_date",
              "detail": "Done at intake for the recent low-trauma fracture: no vertebral fracture",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-BHOF-2022",
                "GL-AACE-2020"
              ]
            },
            {
              "domain": "examination",
              "measure": "Standing height by stadiometer",
              "cadence": "Yearly; vertebral imaging again if height falls 2 cm or more",
              "status": "up_to_date",
              "detail": "164.0 cm at intake",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-BHOF-2022",
                "GL-AACE-2020"
              ]
            },
            {
              "domain": "examination",
              "measure": "Fall-risk screen",
              "cadence": "Yearly, and with any fall",
              "status": "up_to_date",
              "detail": "At intake: Timed Up and Go 11 seconds, tandem stance 8 seconds, chair stand 11; fall with fracture in the past year",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-CDC-STEADI"
              ]
            },
            {
              "domain": "survey",
              "measure": "FRAX 10-year fracture risk",
              "cadence": "At baseline and when risk factors change",
              "status": "up_to_date",
              "detail": "22 percent major osteoporotic and 3.6 percent hip at intake; no change in risk factors",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-BHOF-2022",
                "GL-AACE-2020"
              ]
            },
            {
              "domain": "survey",
              "measure": "Calcium intake assessment",
              "cadence": "At baseline and yearly",
              "status": "completed_today",
              "detail": "About 1200 mg a day from food by three-day record, up from about 800 mg",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-BHOF-2022",
                "GL-AACE-2020"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Dental examination before an antiresorptive",
              "cadence": "Before starting a bisphosphonate or denosumab",
              "status": "due",
              "detail": "Routine dental examination booked next month, before the first infusion",
              "guideline_ids": [
                "GL-AACE-2020",
                "GL-BHOF-2022"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Drug-holiday eligibility",
              "cadence": "After 3 yearly zoledronic acid doses or 5 years of an oral bisphosphonate",
              "status": "not_indicated",
              "detail": "No drug started yet",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-BHOF-2022",
                "GL-AACE-2020"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Denosumab continuity check",
              "cadence": "Every 6 months on denosumab",
              "status": "not_indicated",
              "detail": "Not on denosumab",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-BHOF-2022",
                "GL-AACE-2020"
              ]
            },
            {
              "domain": "referral",
              "measure": "Endocrinology consultation",
              "cadence": "When the diagnosis, risk category, or drug choice needs specialist review",
              "status": "completed_today",
              "detail": "Seen today; treatment indicated; zoledronic acid recommended after vitamin D repletion",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-BHOF-2022",
                "GL-AACE-2020",
                "GL-ENDO-2019"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Balance and strength exercise program",
              "cadence": "With a history of falls or impaired balance",
              "status": "referred",
              "detail": "Physical therapist program begins next week",
              "guideline_ids": [
                "GL-CDC-STEADI",
                "GL-USPSTF-FALLS-2024"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Recovery check (alcohol, cravings, stress)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No alcohol; no cravings",
              "guideline_ids": [
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "survey",
              "measure": "Suicide-risk review and safety plan, with the 988 Suicide & Crisis Lifeline",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No thoughts of suicide or self-harm; the 988 Suicide & Crisis Lifeline is saved in her phone",
              "guideline_ids": [
                "GL-SUICIDE-2024",
                "GL-SUD-2021"
              ]
            }
          ],
          "follow_up": "Balance program from next week. Dental examination next month. 24-hour urine collection before the next visit. Bone health review in two months with pre-infusion tests and the first infusion",
          "guideline_ids": [
            "GL-CMID-2026",
            "GL-BHOF-2022",
            "GL-AACE-2020",
            "GL-ENDO-2019",
            "GL-CDC-STEADI",
            "GL-SUD-2021",
            "GL-SUICIDE-2024"
          ]
        }
      },
      {
        "id": "ENC-003",
        "display": "Three-month bone health review and first zoledronic acid infusion",
        "status": "finished",
        "date": "2026-05-12",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-03"
        },
        "documentation": {
          "chief_complaint": "Three-month bone health review before the first zoledronic acid infusion",
          "hpi": {
            "narrative": "Ms. Richards returns three months after intake. She has taken vitamin D3 2000 units every day and keeps her calcium at about 1200 mg a day from food. She collected the 24-hour urine sample over the weekend, and the result came back this morning with her blood tests. Her routine dental examination three weeks ago found no problems and no dental work is planned. She finished all 16 sessions of the balance and strength program four days ago and now does the home program three times a week. She has had no falls. She has had no alcohol. She has read about the infusion and asked about the flu-like reaction that can follow a first dose.",
            "elements": [
              {
                "label": "Vitamin D",
                "value": "D3 2000 units daily, no missed doses"
              },
              {
                "label": "Dental status",
                "value": "Routine examination three weeks ago; no work planned"
              },
              {
                "label": "Balance program",
                "value": "16 of 16 sessions; home program three times a week"
              },
              {
                "label": "Falls",
                "value": "None"
              },
              {
                "label": "Recovery",
                "value": "No alcohol; no cravings"
              }
            ]
          },
          "ros": [
            {
              "system": "Musculoskeletal",
              "status": "negative",
              "finding": "No bone, back, or thigh pain"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "No kidney stones or urinary symptoms"
            },
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "No fever or recent illness; drinking plenty of fluid today"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood good; no cravings; no thoughts of self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; weight 66.4 kg"
            },
            {
              "system": "Mouth",
              "finding": "Good dentition; no exposed bone"
            },
            {
              "system": "Gait and balance",
              "finding": "Timed Up and Go 9 seconds; tandem stance 18 seconds"
            },
            {
              "system": "Spine",
              "finding": "No tenderness or kyphosis"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-001",
              "display": "Low bone mass with high fracture risk by FRAX, starting treatment",
              "assessment": "25-hydroxyvitamin D 38 ng/mL, now at target. Calcium 9.5 mg/dL, creatinine 0.8 mg/dL, eGFR 81, and 24-hour urine calcium 172 mg, all normal, so the secondary-causes work-up is complete and shows no cause. Dental examination done. Ready for the first dose",
              "plan": [
                "Zoledronic acid 5 mg intravenously over 30 minutes in the infusion room today, after a glass of water",
                "Acetaminophen 1000 mg every 6 hours as needed for up to three days for the aches or fever that can follow a first dose",
                "Continue vitamin D3 2000 units daily and calcium from food",
                "Fasting morning CTX and calcium at the six-month visit"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "History of falls",
              "assessment": "Balance much improved after the program: tandem stance 18 seconds, up from 8; Timed Up and Go 9 seconds, down from 11; no falls",
              "plan": [
                "Home balance and strength program three times a week"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Alcohol use disorder in sustained remission",
              "assessment": "No alcohol or cravings. Safety reviewed: no thoughts of suicide or self-harm; the 988 Suicide & Crisis Lifeline is saved in her phone",
              "plan": [
                "Continue the recovery check at each visit"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "laboratory",
              "measure": "25-hydroxyvitamin D",
              "cadence": "At baseline; after repletion until 30 ng/mL or more; then yearly",
              "status": "completed_today",
              "detail": "38 ng/mL, up from 24; at target; next yearly",
              "observation_ids": [
                "OBS-VITD-V3"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-BHOF-2022",
                "GL-AACE-2020"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Serum calcium before each intravenous antiresorptive dose",
              "cadence": "Before each zoledronic acid dose",
              "status": "completed_today",
              "detail": "9.5 mg/dL, normal; infusion given",
              "observation_ids": [
                "OBS-CA-V3"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-BHOF-2022",
                "GL-AACE-2020"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Creatinine and eGFR before each zoledronic acid dose",
              "cadence": "Before each dose; do not give if creatinine clearance is below 35 mL/min",
              "status": "completed_today",
              "detail": "Creatinine 0.8 mg/dL, eGFR 81",
              "observation_ids": [
                "OBS-CREAT-V3",
                "OBS-EGFR-V3"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-BHOF-2022",
                "GL-AACE-2020"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "24-hour urine calcium",
              "cadence": "At diagnosis, before starting therapy",
              "status": "completed_today",
              "detail": "172 mg in 24 hours, normal; no hypercalciuria. Deviation: collected about three months after it was ordered, because the sample was missed before the four-week visit. No harm resulted: no drug was started until it was done, and the result is normal. Corrective action: baseline tests that need a home collection are now scheduled with the patient before she leaves the intake visit",
              "observation_ids": [
                "OBS-UCA24-V3"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-BHOF-2022",
                "GL-AACE-2020",
                "GL-ENDO-2019"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Bone-turnover marker (fasting serum CTX)",
              "cadence": "Baseline, then 3 to 6 months after starting or changing therapy",
              "status": "due",
              "detail": "Baseline 560 pg/mL; repeat at the six-month visit, three months after today's dose",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-BHOF-2022",
                "GL-AACE-2020"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Dental examination before an antiresorptive",
              "cadence": "Before starting a bisphosphonate or denosumab",
              "status": "completed_today",
              "detail": "Routine examination three weeks ago with no problems; no invasive dental work planned",
              "guideline_ids": [
                "GL-AACE-2020",
                "GL-BHOF-2022"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "First zoledronic acid dose",
              "cadence": "Yearly",
              "status": "completed_today",
              "detail": "5 mg intravenously over 30 minutes; acetaminophen plan given for the acute-phase reaction",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-BHOF-2022",
                "GL-AACE-2020",
                "GL-ENDO-2019"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Central DXA of the spine and hip",
              "cadence": "Every 1 to 2 years on therapy until stable, on the same scanner",
              "status": "up_to_date",
              "detail": "Repeat two years after starting therapy",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-BHOF-2022",
                "GL-AACE-2020"
              ]
            },
            {
              "domain": "examination",
              "measure": "Standing height by stadiometer",
              "cadence": "Yearly; vertebral imaging again if height falls 2 cm or more",
              "status": "up_to_date",
              "detail": "164.0 cm at intake; unchanged on today's vital signs",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-BHOF-2022",
                "GL-AACE-2020"
              ]
            },
            {
              "domain": "examination",
              "measure": "Fall-risk screen",
              "cadence": "Yearly, and with any fall",
              "status": "completed_today",
              "detail": "After the balance program: Timed Up and Go 9 seconds, tandem stance 18 seconds; no falls",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-CDC-STEADI"
              ]
            },
            {
              "domain": "survey",
              "measure": "Calcium intake assessment",
              "cadence": "At baseline and yearly",
              "status": "up_to_date",
              "detail": "About 1200 mg a day from food",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-BHOF-2022",
                "GL-AACE-2020"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Drug-holiday eligibility",
              "cadence": "After 3 yearly zoledronic acid doses or 5 years of an oral bisphosphonate",
              "status": "not_indicated",
              "detail": "First dose today; reassess after the third yearly dose",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-BHOF-2022",
                "GL-AACE-2020"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Balance and strength exercise program",
              "cadence": "With a history of falls or impaired balance",
              "status": "completed_today",
              "detail": "16 of 16 sessions finished four days ago; home program three times a week",
              "guideline_ids": [
                "GL-CDC-STEADI",
                "GL-USPSTF-FALLS-2024"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Recovery check (alcohol, cravings, stress)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No alcohol; no cravings",
              "guideline_ids": [
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "survey",
              "measure": "Suicide-risk review and safety plan, with the 988 Suicide & Crisis Lifeline",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No thoughts of suicide or self-harm; the 988 Suicide & Crisis Lifeline is saved in her phone",
              "guideline_ids": [
                "GL-SUICIDE-2024",
                "GL-SUD-2021"
              ]
            }
          ],
          "follow_up": "Zoledronic acid infusion today. Call the clinic for fever lasting more than three days, muscle cramps or tingling, or jaw pain. Six-month bone health review in three months with fasting CTX and calcium",
          "guideline_ids": [
            "GL-CMID-2026",
            "GL-BHOF-2022",
            "GL-AACE-2020",
            "GL-ENDO-2019",
            "GL-CDC-STEADI",
            "GL-SUD-2021",
            "GL-SUICIDE-2024"
          ]
        }
      },
      {
        "id": "ENC-004",
        "display": "Six-month bone health review, three months after the first infusion",
        "status": "finished",
        "date": "2026-08-11",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-03"
        },
        "documentation": {
          "chief_complaint": "Six-month bone health review, three months after the first zoledronic acid infusion",
          "hpi": {
            "narrative": "Ms. Richards returns three months after her first zoledronic acid infusion. The evening after the infusion she had aching muscles and a temperature of 37.9 °C, which settled with acetaminophen and were gone on the third day; she has had no symptoms since. She has had no muscle cramps, tingling, jaw pain, or thigh or groin pain. She takes vitamin D3 2000 units a day and keeps her calcium at about 1200 mg a day from food. She does the home balance program three times a week, walks most days, and has had no falls. She came fasting this morning for her blood tests. She has had no alcohol.",
            "elements": [
              {
                "label": "Infusion reaction",
                "value": "Aches and 37.9 °C for two days after the dose, settled with acetaminophen"
              },
              {
                "label": "Drug safety",
                "value": "No cramps, tingling, jaw pain, or thigh or groin pain"
              },
              {
                "label": "Supplements and diet",
                "value": "D3 2000 units daily; calcium about 1200 mg a day from food"
              },
              {
                "label": "Falls",
                "value": "None; home balance program three times a week"
              },
              {
                "label": "Recovery",
                "value": "No alcohol; no cravings"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "No fever or fatigue since the third day after the infusion"
            },
            {
              "system": "Musculoskeletal",
              "status": "negative",
              "finding": "No bone, thigh, or groin pain; no muscle cramps"
            },
            {
              "system": "Ears, nose, mouth, and throat",
              "status": "negative",
              "finding": "No jaw pain, loose teeth, or mouth sores"
            },
            {
              "system": "Eyes",
              "status": "negative",
              "finding": "No eye pain or redness"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood good; no cravings; no thoughts of self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; weight 66.0 kg"
            },
            {
              "system": "Mouth",
              "finding": "No exposed bone or gum swelling"
            },
            {
              "system": "Musculoskeletal",
              "finding": "No thigh tenderness; full painless hip movement"
            },
            {
              "system": "Gait and balance",
              "finding": "Timed Up and Go 9 seconds; tandem stance 20 seconds"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-001",
              "display": "Low bone mass with high fracture risk, on zoledronic acid",
              "assessment": "Fasting CTX 190 pg/mL, 66 percent lower than the baseline of 560, showing the expected response. Calcium 9.3 mg/dL. The acute-phase reaction after the first dose was mild and brief and usually does not recur with later doses. No signs of osteonecrosis of the jaw or atypical femoral fracture",
              "plan": [
                "Continue vitamin D3 2000 units daily and calcium from food",
                "Second yearly dose in May after calcium, creatinine, and 25-hydroxyvitamin D",
                "DXA two years after starting; reassess for a drug holiday after the third yearly dose"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "History of falls",
              "assessment": "No falls in six months; balance gains kept up with the home program",
              "plan": [
                "Continue the home balance and strength program"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Alcohol use disorder in sustained remission",
              "assessment": "No alcohol or cravings. Safety reviewed: no thoughts of suicide or self-harm; the 988 Suicide & Crisis Lifeline is saved in her phone",
              "plan": [
                "Continue the recovery check at each visit"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "laboratory",
              "measure": "Bone-turnover marker (fasting serum CTX)",
              "cadence": "Baseline, then 3 to 6 months after starting or changing therapy",
              "status": "completed_today",
              "detail": "190 pg/mL, 66 percent below the baseline of 560; response and adherence confirmed",
              "observation_ids": [
                "OBS-CTX-V4"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-BHOF-2022",
                "GL-AACE-2020",
                "GL-ENDO-2019"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Serum calcium",
              "cadence": "Before each zoledronic acid dose, and after the first dose if symptoms suggest hypocalcemia",
              "status": "completed_today",
              "detail": "9.3 mg/dL, normal; checked with the CTX sample",
              "observation_ids": [
                "OBS-CA-V4"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-BHOF-2022",
                "GL-AACE-2020"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "25-hydroxyvitamin D",
              "cadence": "After repletion until 30 ng/mL or more; then yearly",
              "status": "up_to_date",
              "detail": "38 ng/mL in May; next with the pre-infusion tests in May",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-BHOF-2022",
                "GL-AACE-2020"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Acute-phase reaction after zoledronic acid",
              "cadence": "After the first dose",
              "status": "completed_today",
              "detail": "Aches and 37.9 °C for two days, settled with acetaminophen; acetaminophen offered again for the next dose",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-BHOF-2022",
                "GL-AACE-2020"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Osteonecrosis of the jaw and atypical femoral fracture symptoms",
              "cadence": "At each visit on antiresorptive therapy",
              "status": "completed_today",
              "detail": "No jaw pain or exposed bone; no thigh or groin pain; routine dental care twice a year",
              "guideline_ids": [
                "GL-AACE-2020",
                "GL-BHOF-2022"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Central DXA of the spine and hip",
              "cadence": "Every 1 to 2 years on therapy until stable, on the same scanner",
              "status": "up_to_date",
              "detail": "Due two years after starting therapy, on the same scanner",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-BHOF-2022",
                "GL-AACE-2020"
              ]
            },
            {
              "domain": "examination",
              "measure": "Standing height by stadiometer",
              "cadence": "Yearly; vertebral imaging again if height falls 2 cm or more",
              "status": "up_to_date",
              "detail": "164.0 cm, unchanged",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-BHOF-2022",
                "GL-AACE-2020"
              ]
            },
            {
              "domain": "examination",
              "measure": "Fall-risk screen",
              "cadence": "Yearly, and with any fall",
              "status": "completed_today",
              "detail": "Timed Up and Go 9 seconds, tandem stance 20 seconds; no falls",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-CDC-STEADI"
              ]
            },
            {
              "domain": "survey",
              "measure": "FRAX 10-year fracture risk",
              "cadence": "At baseline, when risk factors change, and at the drug-holiday decision",
              "status": "up_to_date",
              "detail": "No change in risk factors; next at the drug-holiday decision",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-BHOF-2022",
                "GL-AACE-2020"
              ]
            },
            {
              "domain": "survey",
              "measure": "Calcium intake assessment",
              "cadence": "At baseline and yearly",
              "status": "up_to_date",
              "detail": "About 1200 mg a day from food",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-BHOF-2022",
                "GL-AACE-2020"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Drug-holiday eligibility",
              "cadence": "After 3 yearly zoledronic acid doses or 5 years of an oral bisphosphonate",
              "status": "not_indicated",
              "detail": "One dose so far; reassess after the third yearly dose",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-BHOF-2022",
                "GL-AACE-2020"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Balance and strength exercise program",
              "cadence": "With a history of falls or impaired balance",
              "status": "up_to_date",
              "detail": "Home program three times a week",
              "guideline_ids": [
                "GL-CDC-STEADI",
                "GL-USPSTF-FALLS-2024"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Recovery check (alcohol, cravings, stress)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No alcohol; no cravings",
              "guideline_ids": [
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "survey",
              "measure": "Suicide-risk review and safety plan, with the 988 Suicide & Crisis Lifeline",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No thoughts of suicide or self-harm; the 988 Suicide & Crisis Lifeline is saved in her phone",
              "guideline_ids": [
                "GL-SUICIDE-2024",
                "GL-SUD-2021"
              ]
            }
          ],
          "follow_up": "Adult preventive visit in October. Second zoledronic acid dose in May with pre-infusion tests. Call for jaw pain, thigh or groin pain, or any fall",
          "guideline_ids": [
            "GL-CMID-2026",
            "GL-BHOF-2022",
            "GL-AACE-2020",
            "GL-ENDO-2019",
            "GL-CDC-STEADI",
            "GL-SUD-2021",
            "GL-SUICIDE-2024"
          ]
        }
      },
      {
        "id": "ENC-005",
        "display": "Adult preventive visit",
        "status": "finished",
        "date": "2026-10-06",
        "visit_type": "preventive_adult",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "86013001",
          "display": "Periodic reevaluation and management of healthy individual",
          "validation_status": "validated",
          "validated_on": "2026-11-03"
        },
        "documentation": {
          "chief_complaint": "Adult preventive visit; no new complaints",
          "billing_note": "CPT 99396 (periodic preventive medicine visit, established patient, 40 to 64 years) with CPT 99497 (advance care planning), on the same day",
          "hpi": {
            "narrative": "Ms. Richards is a 64-year-old woman who returns for her yearly preventive visit, eight weeks after her six-month bone health review. She has low bone mass with a high 10-year fracture risk and had her first yearly zoledronic acid infusion in May. She takes vitamin D3 2000 units a day and gets about 1200 mg of calcium a day from food. She keeps up the home balance program three times a week, walks most days, and lifts weights twice a week. She has had no falls. She has had no alcohol and remains in sustained remission. She completed the health risk assessment before the visit and has no new concerns.",
            "elements": [
              {
                "label": "Visit",
                "value": "Adult preventive visit"
              },
              {
                "label": "Safety events",
                "value": "No falls, fractures, emergency visits, or hospital stays this year"
              },
              {
                "label": "Medicines",
                "value": "Vitamin D3 2000 units daily; zoledronic acid once a year (next dose in May); no over-the-counter sleep aids or sedatives"
              },
              {
                "label": "Active conditions",
                "value": "Low bone mass with high fracture risk, on treatment; alcohol use disorder in sustained remission; history of falls, none this year"
              },
              {
                "label": "Functional status",
                "value": "Independent; travels most weeks for work"
              }
            ]
          },
          "health_risk_assessment": [
            {
              "domain": "Self-rated health",
              "finding": "Very good"
            },
            {
              "domain": "Psychosocial",
              "finding": "Busy with speaking and advisory work; close family and friends; no loneliness; stress manageable"
            },
            {
              "domain": "Tobacco",
              "finding": "Former smoker; no tobacco or vaping for more than fifteen years"
            },
            {
              "domain": "Alcohol and drugs",
              "finding": "No alcohol (AUDIT-C 0); no other drug use; recovery steady"
            },
            {
              "domain": "Physical activity",
              "finding": "Walks 30 minutes most days, weight training twice a week, balance routine three times a week"
            },
            {
              "domain": "Nutrition",
              "finding": "About 1200 mg of calcium a day from food; protein at each meal; two cups of coffee a day"
            },
            {
              "domain": "Sleep",
              "finding": "About seven hours a night; some short nights when traveling"
            },
            {
              "domain": "Activities of daily living",
              "finding": "Independent"
            },
            {
              "domain": "Instrumental activities of daily living",
              "finding": "Independent, including driving, finances, and medicines"
            },
            {
              "domain": "Home safety",
              "finding": "Stair rails on both sides, night lights, no loose rugs; smoke detectors working; seat belt always"
            },
            {
              "domain": "Falls",
              "finding": "No falls this year; less fear of falling since the balance program"
            },
            {
              "domain": "Hearing and vision",
              "finding": "Reading glasses; eye examination this year; no hearing difficulty"
            },
            {
              "domain": "Memory",
              "finding": "No concerns"
            }
          ],
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "Weight stable; no fever, night sweats, or unusual fatigue"
            },
            {
              "system": "Eyes",
              "status": "negative",
              "finding": "No change in vision with reading glasses"
            },
            {
              "system": "Ears, nose, mouth, and throat",
              "status": "negative",
              "finding": "No hearing change; no jaw pain, loose teeth, or mouth sores"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No chest pain, palpitations, or ankle swelling"
            },
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "No cough or breathlessness"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "No abdominal pain, swallowing difficulty, or change in bowel habit"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "No urinary symptoms; no postmenopausal bleeding"
            },
            {
              "system": "Musculoskeletal",
              "status": "negative",
              "finding": "No bone, back, hip, or thigh pain; no new fracture"
            },
            {
              "system": "Integumentary",
              "status": "negative",
              "finding": "No new or changing skin lesions"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No dizziness, weakness, or numbness"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood good; no cravings; PHQ-2 score 0"
            },
            {
              "system": "Breast",
              "status": "negative",
              "finding": "No lump, pain, or nipple discharge"
            }
          ],
          "exam": [
            {
              "system": "Constitutional",
              "finding": "Well and energetic; weight 65.8 kg, BMI 24.5; stadiometer height 164.0 cm, unchanged since February"
            },
            {
              "system": "Eyes",
              "finding": "Pupils equal and reactive; near vision 20/25 with reading glasses"
            },
            {
              "system": "Ears, nose, and throat",
              "finding": "Canals clear; whispered-voice test passed on both sides; good dentition, no exposed bone"
            },
            {
              "system": "Neck",
              "finding": "No thyroid enlargement or nodes"
            },
            {
              "system": "Breasts",
              "finding": "Clinical breast examination offered and declined; no concerns reported"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm at 70 per minute; no murmur; no edema"
            },
            {
              "system": "Respiratory",
              "finding": "Clear to auscultation"
            },
            {
              "system": "Abdomen",
              "finding": "Soft and non-tender; no masses"
            },
            {
              "system": "Musculoskeletal",
              "finding": "No spinal tenderness or kyphosis; occiput touches the wall; Timed Up and Go 9 seconds; tandem stance 20 seconds"
            },
            {
              "system": "Neurological",
              "finding": "Alert and oriented; gait steady"
            },
            {
              "system": "Psychiatric",
              "finding": "Euthymic, engaged, and quick-witted"
            },
            {
              "system": "Skin",
              "finding": "No suspicious lesions"
            }
          ],
          "assessment_plan": [
            {
              "display": "Adult preventive visit completed",
              "assessment": "Health risk assessment reviewed and a written prevention plan given. Depression, alcohol, and fall-risk screens are negative. 10-year atherosclerotic cardiovascular risk about 5 percent (total cholesterol 204, HDL 62, systolic 122, nonsmoker, no diabetes), below the threshold for a statin",
              "plan": [
                "Influenza and PCV20 vaccines today",
                "COVID-19 vaccine at her pharmacy this month",
                "Next mammogram in about ten months",
                "Next preventive visit in one year"
              ]
            },
            {
              "problem_id": "PRB-001",
              "display": "Low bone mass with high fracture risk, on zoledronic acid",
              "assessment": "First yearly dose given in May; CTX fell 66 percent by August. Height unchanged, no falls or fractures, no jaw or thigh symptoms",
              "plan": [
                "Continue vitamin D3 2000 units daily and calcium from food",
                "Second dose in May after calcium, creatinine, and 25-hydroxyvitamin D",
                "DXA two years after starting"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Alcohol use disorder in sustained remission",
              "assessment": "No alcohol; AUDIT-C 0. Safety reviewed: no thoughts of suicide or self-harm; the 988 Suicide & Crisis Lifeline is saved in her phone",
              "plan": [
                "Continue the recovery check at each visit",
                "No sedating medicines"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "History of falls",
              "assessment": "No falls this year; balance and gait improved since the exercise program",
              "plan": [
                "Continue the home balance program three times a week",
                "Yearly fall-risk screen and eye examination"
              ]
            }
          ],
          "prevention_plan": [
            {
              "service": "Influenza vaccine, this season",
              "status": "completed_today",
              "detail": "Inactivated vaccine given today",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Pneumococcal vaccine",
              "status": "completed_today",
              "detail": "PCV20 given today; recommended once for all adults 50 and older; no further dose needed",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "COVID-19 vaccine, this season",
              "status": "due",
              "detail": "Recommended; she will get it at her pharmacy this month",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Recombinant zoster vaccine",
              "status": "up_to_date",
              "detail": "Two-dose series completed three years ago",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Tetanus, diphtheria, and pertussis booster",
              "status": "up_to_date",
              "detail": "Tdap seven years ago; next due in about three years",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "RSV vaccine",
              "status": "not_indicated",
              "detail": "Recommended at 50 to 74 only with a risk condition; she has none",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Breast cancer screening",
              "status": "up_to_date",
              "detail": "Screening mammogram every two years from 40 to 74; last normal 14 months ago; next in about ten months",
              "guideline_ids": [
                "GL-USPSTF-BREAST-2024"
              ]
            },
            {
              "service": "Cervical cancer screening",
              "status": "up_to_date",
              "detail": "HPV test negative three years ago with earlier normal results; screening can stop after 65 with adequate negative results",
              "guideline_ids": [
                "GL-USPSTF-CERV-2018"
              ]
            },
            {
              "service": "Colorectal cancer screening",
              "status": "up_to_date",
              "detail": "Colonoscopy normal six years ago; next in four years",
              "guideline_ids": [
                "GL-USPSTF-CRC-2021"
              ]
            },
            {
              "service": "Lung cancer screening",
              "status": "not_indicated",
              "detail": "Former heavy smoker, but she quit more than 15 years ago, so she does not meet the criteria",
              "guideline_ids": [
                "GL-USPSTF-LUNG-2021"
              ]
            },
            {
              "service": "Cholesterol screening and statin decision",
              "status": "completed_today",
              "detail": "LDL 118 mg/dL; 10-year risk about 5 percent; no statin; recheck in five years or if risk changes",
              "guideline_ids": [
                "GL-USPSTF-STATIN-2022"
              ]
            },
            {
              "service": "Diabetes screening",
              "status": "not_indicated",
              "detail": "Recommended at 35 to 70 with overweight or obesity; BMI 24.5",
              "guideline_ids": [
                "GL-USPSTF-DM-2021"
              ]
            },
            {
              "service": "Blood pressure screening",
              "status": "completed_today",
              "detail": "122/74 mmHg",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Hepatitis C and HIV screening",
              "status": "up_to_date",
              "detail": "One-time screening for both done in the past, negative",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Depression screening",
              "status": "completed_today",
              "detail": "PHQ-2 score 0; PHQ-9 2 in February",
              "guideline_ids": [
                "GL-USPSTF-DEP-2023"
              ]
            },
            {
              "service": "Unhealthy alcohol use screening",
              "status": "completed_today",
              "detail": "AUDIT-C 0; sustained remission",
              "guideline_ids": [
                "GL-USPSTF-ALCOHOL-2018"
              ]
            },
            {
              "service": "Tobacco use",
              "status": "completed_today",
              "detail": "Former smoker; no use",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Osteoporosis screening",
              "status": "not_indicated",
              "detail": "Already diagnosed and on treatment; follow-up DXA two years after starting",
              "guideline_ids": [
                "GL-USPSTF-OSTEO-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "service": "Falls prevention",
              "status": "completed_today",
              "detail": "No falls; Timed Up and Go 9 seconds; home balance program continues",
              "guideline_ids": [
                "GL-CDC-STEADI"
              ]
            },
            {
              "service": "Physical activity and diet counseling",
              "status": "completed_today",
              "detail": "Weight-bearing, strength, and balance exercise; calcium from food"
            },
            {
              "service": "Eye examination",
              "status": "up_to_date",
              "detail": "Done this year"
            }
          ],
          "advance_care_planning": "Voluntary advance care planning discussion of about 20 minutes, with her consent. We talked about why it helps to choose a health care agent and to put wishes in writing while she is well. She named a health care agent, who is recorded in the chart and not named here, and took a medical power of attorney form and a directive form home to complete. She said what matters most to her is staying independent and being told the plain truth about her health so she can make her own decisions. She chose not to record specific treatment preferences today. The plan will be revisited next year or sooner if her health changes.",
          "follow_up": "COVID-19 vaccine at her pharmacy. Mammogram in about ten months. Second zoledronic acid dose in May with pre-infusion tests. Next preventive visit in one year",
          "guideline_ids": [
            "GL-PREV-2026",
            "GL-USPSTF-AB",
            "GL-CDC-IMZ-2026",
            "GL-CMID-2026",
            "GL-SUICIDE-2024"
          ]
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic adult preventive visit; no synthetic illness episode is added under the recent-death rule.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      }
    ],
    "vital_sign_sets": [
      {
        "id": "VSET-001",
        "date": "2026-02-10",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 164.0,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 66.0,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 24.5,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 124,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 76,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 72,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs with stadiometer height; no measurement from her lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "VSET-002",
        "date": "2026-03-10",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 164.0,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 66.2,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 24.6,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 122,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 74,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 70,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.7,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs with stadiometer height; no measurement from her lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "VSET-003",
        "date": "2026-05-12",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 164.0,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 66.4,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 24.7,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 120,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 74,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 72,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 99,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs with stadiometer height; no measurement from her lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "VSET-004",
        "date": "2026-08-11",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 164.0,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 66.0,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 24.5,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 122,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 76,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 68,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.7,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs with stadiometer height; no measurement from her lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "VSET-005",
        "date": "2026-10-06",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 164.0,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 65.8,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 24.5,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 122,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 74,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 70,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs and stadiometer height at the preventive visit, continuing the trend of the earlier visits.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      }
    ],
    "social_history": [
      {
        "id": "SOC-001",
        "display": "Alcohol use disorder in sustained remission: no alcohol for more than fifteen years since treatment; AUDIT-C 0",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003"
          ],
          "synthetic_reason": "Synthetic modern entry anchored to her public account of heavy drinking and recovery.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "SOC-002",
        "display": "Former smoker by her own account; smoked heavily for many years and quit more than fifteen years ago (quit timing and amount are synthetic); no vaping",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003"
          ],
          "synthetic_reason": "Synthetic tobacco history anchored to her public phrase about smoking; no source dates her quitting.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "SOC-003",
        "display": "Former statewide officeholder, now a public speaker and policy adviser who travels most weeks; divorced; lives alone in her own two-story home; adult children live nearby",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0002"
          ],
          "synthetic_reason": "Synthetic modern occupation and living situation echoing her documented career; family members are unnamed and give no statements.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "SOC-004",
        "display": "Exercise: walks about 30 minutes most days and began weight training at a gym after her fall; no balance training",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic exercise history anchored to her public account of weight-bearing exercise and weight training.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "SOC-005",
        "display": "Diet: about 800 mg of calcium a day from food (milk in coffee, cheese, yogurt a few times a week); two cups of coffee a day; no calcium or vitamin D supplements; uses sunscreen and works mostly indoors",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic dietary history for the calcium and vitamin D assessment.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "SOC-006",
        "display": "Natural menopause in her early fifties; no hormone therapy; no glucocorticoid, anticonvulsant, aromatase inhibitor, or proton pump inhibitor use",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic reproductive and drug-exposure history for the secondary-causes review.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      }
    ],
    "functional_status": [
      {
        "id": "FUNC-001",
        "display": "Independent in all activities of daily living and instrumental activities. Timed Up and Go 11 seconds; tandem stance held 8 seconds (below 10); 30-second chair stand 11; fall with fracture in the past year and fear of another fall when traveling",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic CDC STEADI falls assessment after her documented falls.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "FUNC-002",
        "display": "Standing height 164.0 cm by stadiometer, about 2 cm below her recalled tallest height of 166 cm; no kyphosis; occiput touches the wall",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic height measurement consistent with the three-quarters of an inch of height loss reported in the press.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      }
    ],
    "mental_status": [
      {
        "id": "MSE-001",
        "display": "Alert, quick-witted, and direct; asks pointed questions about her numbers",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic mental-status finding.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "MSE-002",
        "display": "Mood good; PHQ-9 score 2 with item 9 scored 0; no thoughts of suicide or self-harm; no cravings",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic mental-status finding.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      }
    ],
    "safety_assessment": {
      "id": "SAFE-001",
      "date": "2026-02-10",
      "current_ideation": "absent",
      "intent": "absent",
      "plan": "absent",
      "access_reviewed": true,
      "protective_factors": [
        "More than fifteen years of sustained recovery",
        "Purposeful work and a strong public voice",
        "Close family and long-time friends",
        "Engagement in primary care"
      ],
      "disposition": "Routine outpatient care. Crisis resources, including the 988 Suicide & Crisis Lifeline, given in writing and saved in her phone; safety reviewed at each visit",
      "provenance": {
        "evidence_grade": "S",
        "claim_ids": [
          "CLM-0003"
        ],
        "synthetic_reason": "Synthetic present-day structured safety assessment required by the alcohol use disorder code; it records no current risk and makes no claim about her real mental health.",
        "author": "The Human Record generator",
        "created": "2026-11-03T23:00:00-05:00"
      }
    },
    "consultation": {
      "referral": {
        "question": "Low bone mass on DXA with a FRAX risk above the treatment thresholds in a 63-year-old woman after a fall with a hand fracture. Please confirm how to classify her, whether to treat and with what, and how to monitor",
        "urgency": "Routine, within four weeks",
        "pertinent_history": "Postmenopausal since her early fifties, no hormone therapy, no glucocorticoids. Fell from standing height last year and broke her hand; one account also describes a second fall with an ankle fracture. She was told after an earlier test that she had early bone loss; no report is available. Her mother had osteoporosis with arm and hip fractures. Former heavy smoker, quit more than fifteen years ago; alcohol use disorder in sustained remission for more than fifteen years. Height 164.0 cm, about 2 cm below her recalled tallest; BMI 24.5. DXA today: lumbar spine T-score -2.3, femoral neck -2.0, total hip -1.7. Lateral spine DXA: no vertebral fracture. FRAX with femoral neck BMD (previous fracture and parental hip fracture entered): 22 percent major osteoporotic, 3.6 percent hip. Calcium 9.4, albumin 4.2, phosphate, magnesium, alkaline phosphatase, PTH 54, creatinine 0.8 (eGFR 81), TSH, and hemoglobin normal; 25-hydroxyvitamin D 24 ng/mL; fasting CTX 560 pg/mL; 24-hour urine calcium ordered. Calcium intake about 800 mg a day. Timed Up and Go 11 seconds, tandem stance 8 seconds. Started vitamin D3 2000 units daily today",
        "questions": [
          "Is this osteoporosis or low bone mass, and should the hand fracture count as a fragility fracture in FRAX and in the diagnosis?",
          "Is drug treatment indicated, and what is her risk category?",
          "Which drug do you recommend for her, and what has to be in place before the first dose?",
          "Is the secondary-causes work-up adequate?",
          "How should we monitor her, when should DXA be repeated, and how long should treatment last before a drug holiday is considered?",
          "Do her falls, her past smoking, or her alcohol use disorder in remission change the plan?"
        ]
      },
      "consultant_note": {
        "history": "Ms. Richards is seen at the request of Dr. Teague four weeks after her intake visit. She fell from standing height last year and broke her hand, and one account describes a second fall with an ankle fracture. She watched her mother live with fractures of the arm and hip and a curved back, and she wants to avoid that. She went through menopause in her early fifties and took no hormone therapy. She has never taken glucocorticoids or other drugs that harm bone. She smoked heavily for many years and stopped more than fifteen years ago, and she has not had alcohol for more than fifteen years. She walks and lifts weights, and since intake she has raised her calcium intake to about 1200 mg a day from food and taken vitamin D3 2000 units daily. She has no bone pain, kidney stones, or bowel symptoms. She travels most weeks for work and would like a treatment she does not have to remember daily",
        "data_reviewed": "Intake DXA of the spine and hip, the lateral spine vertebral fracture assessment, the FRAX calculation and its inputs, the secondary-causes tests, 25-hydroxyvitamin D, fasting CTX, the three-day food record, and the intake fall-risk assessment. The 24-hour urine calcium has not yet been collected",
        "exam": [
          {
            "system": "General",
            "finding": "Well and animated; height 164.0 cm, weight 66.2 kg"
          },
          {
            "system": "Spine",
            "finding": "No tenderness or kyphosis; occiput touches the wall"
          },
          {
            "system": "Mouth",
            "finding": "Good dentition; no exposed bone"
          },
          {
            "system": "Thyroid",
            "finding": "Not enlarged; no nodules"
          },
          {
            "system": "Gait and balance",
            "finding": "Gait steady; tandem stance 8 seconds"
          }
        ],
        "assessment": [
          {
            "problem_id": "PRB-001",
            "display": "Low bone mass with high fracture risk",
            "assessment": "By T-score this is low bone mass, not osteoporosis: the lowest value is -2.3 at the lumbar spine, and none is -2.5 or lower. The phrase early osteoporosis has no defined meaning and should not be used. A hand fracture is not one of the fractures that establishes osteoporosis on its own (hip or vertebra, or in low bone mass a proximal humerus, pelvis, or distal forearm fracture), but it followed a fall from standing height, so it is correctly entered as a previous fracture in FRAX. With that and her mother's hip fracture, FRAX is 22 percent for a major osteoporotic fracture and 3.6 percent for hip fracture, above the thresholds of 20 and 3 percent. Treatment is indicated by the BHOF 2022 and Endocrine Society thresholds, and AACE 2020 would call this osteoporosis on clinical grounds. By AACE 2020 she is in the very-high-risk group because of a fall with injury and a fracture within about the past year; she does not meet the Endocrine Society very-high-risk criteria, which center on severe or multiple vertebral fractures"
          },
          {
            "display": "Drug choice",
            "assessment": "Zoledronic acid 5 mg once a year is a first-line choice in both the high-risk and very-high-risk groups of AACE 2020 and is an initial therapy in the Endocrine Society guideline, with proven reduction of hip, vertebral, and nonvertebral fractures. Once-yearly dosing suits her travel. Anabolic therapy was discussed; with no vertebral fracture and no T-score below -2.5 it is not needed first, and it remains the option if she fractures on treatment. An oral bisphosphonate is a reasonable alternative. A selective estrogen receptor modulator is not suitable, because it has not been shown to reduce hip fractures and her hip risk is above threshold. Before the first dose, 25-hydroxyvitamin D must be 30 ng/mL or more, calcium and eGFR must be normal (creatinine clearance 35 mL/min or more), and a routine dental examination should be done"
          },
          {
            "display": "Secondary causes",
            "assessment": "Normal calcium, PTH, phosphate, magnesium, alkaline phosphatase, kidney function, TSH, and blood count make hyperparathyroidism, osteomalacia, thyroid excess, and myeloma unlikely. Vitamin D of 24 ng/mL is insufficient and is being corrected. The 24-hour urine calcium is still needed to exclude hypercalciuria before treatment. Celiac serology and protein electrophoresis are not needed without bowel symptoms, anemia, or an unexplained abnormal result"
          },
          {
            "problem_id": "PRB-003",
            "display": "Falls",
            "assessment": "Falls cause most of her fracture risk outside the spine. Her tandem stance of 8 seconds shows impaired balance; a supervised balance and strength program is the most effective fall-prevention step"
          },
          {
            "problem_id": "PRB-002",
            "display": "Alcohol use disorder in sustained remission",
            "assessment": "Heavy alcohol use and smoking harm bone; her long abstinence from both removes them as current risk factors, so neither is entered as current in FRAX. Remission also lowers her fall risk. No change to the drug plan; avoid sedating medicines"
          }
        ],
        "recommendations": [
          "Treat: zoledronic acid 5 mg intravenously once a year, starting once 25-hydroxyvitamin D is 30 ng/mL or more, calcium and eGFR are normal, and a routine dental examination is done; recheck these at about three months",
          "Collect the 24-hour urine calcium before the first dose",
          "Acetaminophen for the aches and fever that can follow the first dose",
          "Continue vitamin D3 2000 units daily and about 1200 mg of calcium a day, mostly from food",
          "Supervised balance and strength program now, then a home program; weight-bearing exercise most days",
          "Fasting morning CTX three months after the first dose to confirm response; calcium and creatinine before each yearly dose; 25-hydroxyvitamin D yearly",
          "Repeat DXA of the spine and hip two years after starting, on the same scanner",
          "After three yearly doses, recalculate FRAX and reassess: a drug holiday of up to three years is reasonable if she has had no new fracture or injurious fall and the femoral neck T-score is above -2.5; if she remains at very high risk, continue to six yearly doses",
          "Height and fall-risk screen yearly, with repeat vertebral imaging if height falls 2 cm or more"
        ],
        "communication": "Discussed with Dr. Teague the same day; the patient agrees with the plan and asked for once-yearly treatment",
        "follow_up": "Primary care will continue monitoring on the CMID osteoporosis schedule. Endocrinology will see her again for a fracture on treatment, a fall in bone density on the follow-up DXA, an abnormal secondary-causes result, or the drug-holiday decision after the third dose"
      },
      "guideline_ids": [
        "GL-CMID-2026",
        "GL-BHOF-2022",
        "GL-AACE-2020",
        "GL-ENDO-2019",
        "GL-ENDO-2020",
        "GL-CDC-STEADI"
      ]
    }
  },
  "care_plan": {
    "health_concerns": [
      {
        "id": "HC-001",
        "display": "She does not want to break bones and lose her posture the way her mother did",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004"
          ],
          "synthetic_reason": "Synthetic patient-centered concern linked to her public account of her mother.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "HC-002",
        "display": "She wants to keep traveling and speaking without slowing down, and wants a plan she can keep on the road",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic patient-centered concern linked to her book's message.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      }
    ],
    "goals": [
      {
        "id": "GOAL-001",
        "display": "Total calcium intake of about 1200 mg a day, mostly from food, by the four-week visit",
        "status": "completed",
        "target_date": "2026-03-10",
        "outcome": "About 1200 mg a day from food by her own three-day food record",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic nutrition goal.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "GOAL-002",
        "display": "25-hydroxyvitamin D of 30 ng/mL or more before the first infusion",
        "status": "completed",
        "target_date": "2026-05-12",
        "outcome": "24 ng/mL at intake and 38 ng/mL at three months",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic repletion goal.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "GOAL-003",
        "display": "First zoledronic acid dose by the three-month visit, with normal calcium and kidney function and a dental check done",
        "status": "completed",
        "target_date": "2026-05-12",
        "outcome": "Given at three months after normal calcium (9.5 mg/dL) and eGFR (81) and a routine dental examination",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic treatment-start goal.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "GOAL-004",
        "display": "Complete the eight-week balance and strength program, with no falls through six months",
        "status": "completed",
        "target_date": "2026-08-11",
        "outcome": "16 of 16 sessions; Timed Up and Go 9 seconds and tandem stance 20 seconds at six months; no falls",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic falls-prevention goal.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "GOAL-005",
        "display": "Serum CTX at least 30 percent lower three months after the first dose",
        "status": "completed",
        "target_date": "2026-08-11",
        "outcome": "560 pg/mL at baseline and 190 pg/mL at three months after the dose (66 percent lower)",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic response and adherence goal.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "GOAL-006",
        "display": "Sustained remission from alcohol use disorder throughout the episode",
        "status": "completed",
        "target_date": "2026-08-11",
        "outcome": "No alcohol reported at any visit; AUDIT-C 0 at intake",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic recovery goal.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      }
    ],
    "interventions": [
      {
        "id": "INT-001",
        "display": "Endocrinology consultation to confirm the diagnostic category from the T-scores and FRAX, the risk category, the choice of drug, the secondary-causes work-up, and the plan for monitoring and treatment duration",
        "status": "completed",
        "guideline_ids": [
          "GL-CMID-2026",
          "GL-BHOF-2022",
          "GL-AACE-2020",
          "GL-ENDO-2019"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0006",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic specialist consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "INT-002",
        "display": "Drug treatment, because FRAX is above the treatment thresholds, with the agent confirmed at the endocrinology visit: zoledronic acid 5 mg intravenously once a year, given only after 25-hydroxyvitamin D is 30 ng/mL or more, calcium is normal, eGFR is above 35, and a routine dental examination is done; acetaminophen for the expected aches and fever after the first dose; reassess after three yearly doses for a drug holiday",
        "status": "completed",
        "guideline_ids": [
          "GL-CMID-2026",
          "GL-BHOF-2022",
          "GL-AACE-2020",
          "GL-ENDO-2019",
          "GL-ENDO-2020"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic guideline-based drug plan; no product brand is named.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        },
        "recorded_date": "2026-03-10"
      },
      {
        "id": "INT-003",
        "display": "Calcium about 1200 mg a day in total, from food first, and vitamin D3 2000 units a day to reach 30 ng/mL or more, then continue; caffeine kept to two cups of coffee a day; no tobacco or alcohol",
        "status": "completed",
        "guideline_ids": [
          "GL-CMID-2026",
          "GL-BHOF-2022",
          "GL-AACE-2020"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic calcium and vitamin D plan.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "INT-004",
        "display": "Falls prevention by CDC STEADI: supervised balance and strength exercise with a physical therapist for eight weeks, then a home program three times a week; weight-bearing exercise most days; home safety review (stair rails, night lights, no loose rugs); low-heeled shoes when traveling; yearly vision check",
        "status": "completed",
        "guideline_ids": [
          "GL-CDC-STEADI",
          "GL-USPSTF-FALLS-2024",
          "GL-BHOF-2022"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic falls-prevention plan.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "INT-005",
        "display": "Monitoring on the CMID osteoporosis schedule: secondary-causes tests at baseline (calcium, albumin, phosphate, magnesium, alkaline phosphatase, creatinine and eGFR, PTH, 25-hydroxyvitamin D, TSH, blood count, and 24-hour urine calcium); calcium and creatinine before each infusion; fasting CTX at baseline and three to six months after starting; 25-hydroxyvitamin D after repletion and then yearly; height and fall-risk screen yearly; FRAX recalculated when risk factors change; DXA of the spine and hip two years after starting, on the same scanner",
        "status": "completed",
        "guideline_ids": [
          "GL-CMID-2026",
          "GL-AACE-2020",
          "GL-ENDO-2019",
          "GL-USPSTF-OSTEO-2025"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic monitoring plan.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      },
      {
        "id": "INT-006",
        "display": "Recovery-oriented care for alcohol use disorder in sustained remission: ask about alcohol, cravings, and stress at each visit in a non-judgmental way, support the recovery practices she uses, avoid sedating medicines, and review safety with the 988 Suicide & Crisis Lifeline at each visit",
        "status": "completed",
        "guideline_ids": [
          "GL-SUD-2021",
          "GL-SUICIDE-2024",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003"
          ],
          "synthetic_reason": "Synthetic recovery and safety plan.",
          "author": "The Human Record generator",
          "created": "2026-11-03T23:00:00-05:00"
        }
      }
    ],
    "guidelines": [
      {
        "guideline_id": "GL-CMID-2026",
        "title": "CMID: Clinical Monitoring Intelligence Database, osteoporosis monograph",
        "publisher": "Aether Forge",
        "url": "https://patrickrutledge.github.io/topthirty/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-BHOF-2022",
        "title": "The clinician's guide to prevention and treatment of osteoporosis",
        "publisher": "Bone Health and Osteoporosis Foundation (LeBoff MS et al., Osteoporos Int 2022;33(10):2049-2102)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/35478046/",
        "version_or_year": "2022"
      },
      {
        "guideline_id": "GL-AACE-2020",
        "title": "American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis, 2020 Update",
        "publisher": "AACE/ACE (Camacho PM et al., Endocr Pract 2020;26(Suppl 1):1-46)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/32427503/",
        "version_or_year": "2020"
      },
      {
        "guideline_id": "GL-ENDO-2019",
        "title": "Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Clinical Practice Guideline",
        "publisher": "Endocrine Society (Eastell R et al., J Clin Endocrinol Metab 2019;104(5):1595-1622)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/30907953/",
        "version_or_year": "2019"
      },
      {
        "guideline_id": "GL-ENDO-2020",
        "title": "Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Guideline Update",
        "publisher": "Endocrine Society (Shoback D et al., J Clin Endocrinol Metab 2020;105(3):587-594)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/32068863/",
        "version_or_year": "2020"
      },
      {
        "guideline_id": "GL-USPSTF-OSTEO-2025",
        "title": "Osteoporosis to Prevent Fractures: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/osteoporosis-screening",
        "version_or_year": "2025"
      },
      {
        "guideline_id": "GL-USPSTF-FALLS-2024",
        "title": "Falls Prevention in Community-Dwelling Older Adults: Interventions",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/falls-prevention-community-dwelling-older-adults-interventions",
        "version_or_year": "2024"
      },
      {
        "guideline_id": "GL-CDC-STEADI",
        "title": "STEADI: Stopping Elderly Accidents, Deaths, and Injuries",
        "publisher": "Centers for Disease Control and Prevention",
        "url": "https://www.cdc.gov/steadi/index.html",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-SUD-2021",
        "title": "VA/DoD Clinical Practice Guideline for the Management of Substance Use Disorders",
        "publisher": "United States Department of Veterans Affairs and Department of Defense",
        "url": "https://www.healthquality.va.gov/guidelines/MH/sud/",
        "version_or_year": "2021"
      },
      {
        "guideline_id": "GL-SUICIDE-2024",
        "title": "VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide",
        "publisher": "United States Department of Veterans Affairs and Department of Defense",
        "url": "https://healthquality.va.gov/HEALTHQUALITY/guidelines/mh/srb/index.asp",
        "version_or_year": "2024"
      },
      {
        "guideline_id": "GL-PREV-2026",
        "title": "Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements",
        "publisher": "Aether Forge",
        "url": "https://patrickrutledge.github.io/preventative_services/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-AB",
        "title": "USPSTF A and B Recommendations",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/uspstf-a-and-b-recommendations",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-BREAST-2024",
        "title": "Breast Cancer: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening",
        "version_or_year": "2024"
      },
      {
        "guideline_id": "GL-USPSTF-CERV-2018",
        "title": "Cervical Cancer: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/cervical-cancer-screening",
        "version_or_year": "2018"
      },
      {
        "guideline_id": "GL-USPSTF-CRC-2021",
        "title": "Colorectal Cancer: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening",
        "version_or_year": "2021"
      },
      {
        "guideline_id": "GL-USPSTF-LUNG-2021",
        "title": "Lung Cancer: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/lung-cancer-screening",
        "version_or_year": "2021"
      },
      {
        "guideline_id": "GL-USPSTF-STATIN-2022",
        "title": "Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/statin-use-in-adults-preventive-medication",
        "version_or_year": "2022"
      },
      {
        "guideline_id": "GL-USPSTF-DM-2021",
        "title": "Prediabetes and Type 2 Diabetes: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-for-prediabetes-and-type-2-diabetes",
        "version_or_year": "2021"
      },
      {
        "guideline_id": "GL-USPSTF-DEP-2023",
        "title": "Depression and Suicide Risk in Adults: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-depression-suicide-risk-adults",
        "version_or_year": "2023"
      },
      {
        "guideline_id": "GL-USPSTF-ALCOHOL-2018",
        "title": "Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/unhealthy-alcohol-use-in-adolescents-and-adults-screening-and-behavioral-counseling-interventions",
        "version_or_year": "2018"
      },
      {
        "guideline_id": "GL-CDC-IMZ-2026",
        "title": "Adult Immunization Schedule by Age",
        "publisher": "Centers for Disease Control and Prevention",
        "url": "https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-age.html",
        "version_or_year": "2026"
      }
    ]
  },
  "review": {
    "schema_validation": {
      "status": "not_started",
      "notes": "Run scripts/build.ps1 -Conformance."
    },
    "clinical_review": {
      "status": "not_started",
      "notes": "Awaiting clinician review; check the T-score and FRAX reading (low bone mass with FRAX above threshold, and entering the hand fracture as a previous fracture), the AACE risk category, the drug choice, and the deviation recorded for the late 24-hour urine calcium."
    },
    "provenance_review": {
      "status": "not_started",
      "notes": "Recent-death rule: only what Richards made public (her book, interviews, and press coverage) and basic biographical facts are used. Her real T-scores were not found and are not used; her real medicine is not named, and no promotional claim is repeated. The fracture year conflict (1996 or 1994) is recorded."
    },
    "safe_messaging_review": {
      "status": "not_started",
      "notes": "Alcohol and tobacco claims are marked sensitive; recovery is described in person-first, non-stigmatizing language; the safety assessment records no current risk and gives the 988 Suicide & Crisis Lifeline; her later cancer and death are recorded as history only, without detail."
    }
  }
}
